Vlad Muzykantov earned his MD (Internal Medicine) from the First Moscow Medical School in 1980, and PhD in Medical Sciences (Biochemistry) in 1986 from the National Cardiology Research Centre (Moscow), where he worked till 1993, when he moved to PENN, where he serves as the Founding Director of the Center for Targeted Therapeutics and Translational Nanomedicine and Vice-Chair of Department of Pharmacology. His research for last 40 years encompasses drug delivery and targeting in the vascular, respiratory and nervous systems. He published about 250 papers on this topic including Science, numerous Nature series, PNAS, ACS Nano, Blood, Advanced Materials and other high impact journals. In these collaborative studies his team pioneered targeting drugs and carriers to endothelial and blood cells, regulation of targeting and intracellular delivery of numerous drug delivery systems (DDS).